Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized partially-blinded trial of BMS-663068/GSK3684934 in HIV-1 infection
2011-000437-36Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of fostemsavir in human immunodeficiency virus infection (HIV) (4 arms), sponsored by ViiV Healthcare. Primary endpoint: Virologic suppression at Week 24. Started Jul 2011; status: completed.
02
Drugs
fostemsavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2011-000437-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000437-36.